CVI Accepts, published online ahead of print on 4 November 2009
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Ko, Y.-J.
Right arrow Articles by Paik, S.-G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ko, Y.-J.
Right arrow Articles by Paik, S.-G.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00374-09
Copyright (c) 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Use of a Baculovirus-Expressed Structural Protein for the Detection of Antibodies to Foot-and-Mouth Disease Virus Type A by a Blocking Enzyme-Linked Immunosorbent Assay

Young-Joon Ko*, Hyang-Sim Lee, Hye-Young Jeoung, Eun-Jeong Heo, Hyo-Rim Ko, Byung-Sik Chang, Hoo-Don Joo, U. Gerelmaa, B. Dashzeveg, S. Tserendorj, R. Sodnomdarjaa, Jong-Hyeon Park, Chang-Hee Kweon, In-Soo Cho, and Sang-Gi Paik

National Veterinary Research and Quarantine Service, Anyang, Gyeonggi, 430-824, South Korea; Department of Research and Development Laboratory, Jenobiotech Inc., Chuncheon, Gangwon, South Korea; States Central Veterinary Laboratory, Zaisan, Khan-Uul District, Ulaanbaatar 210153, Mongolia; and Department of Biological Science, Chungnam National University, Daejeon, South Korea

* To whom correspondence should be addressed. Email: koyj{at}nvrqs.go.kr.


arrow
Abstract

A blocking enzyme-linked immunosorbent assay using baculovirus-expressed structural protein was developed for the detection of antibodies to foot-and-mouth disease virus type A. It exhibited 99% specificity with cutoff of 53% inhibition. Its sensitivity was comparable to the virus neutralization test and LPB ELISA, indicating its potential as an alternative assay.